Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00842517 · ClinicalTrials.gov registry record · Phase 1
Long Term Maintenance of Drug Abstinence
A Phase 1 study of Cocaine Dependence and Cocaine Abuse, sponsored by Treatment Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 166
- Enrollment target
- 1
- Study location
NCT00842517: Completed Phase 1 study of Cocaine Dependence and Cocaine Abuse, sponsored by Treatment Research Institute.
NCT00842517 is a Phase 1 study of Cocaine Dependence and Cocaine Abuse that has completed, run by Treatment Research Institute. The registered enrollment target is 166 participants, below the 294-participant average among 38 other Cocaine Dependence trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00842517, a Phase 1 study of Cocaine Dependence and Cocaine Abuse, has completed, sponsored by Treatment Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 166 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop a model for long-term maintenance of behavior change by examining the effects of extending the duration of contingency management (CM) for drug abuse on long-term abstinence outcomes. The primary hypothesis is that the Extended (36 week) CM group will have better long-term outcomes as exhibited by greater rates of abstinence at each follow-up assessment as compared to the Standard (12 week) CM group.
Conditions Studied
Interventions
- BEHAVIORAL Contingency Management
Study Locations (1)
Pennsylvania
- Parkside Recovery - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2004-09 |
| Est. Completion | 2008-08 |
| Phase | Phase 1 |
What the finished NCT00842517 record still lists
NCT00842517 is an interventional study that assigns participants to a tested intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap, below the 294-participant average among 38 other Cocaine Dependence trials with a reported enrollment target (44% lower).
The record links to 2 conditions, with Cocaine Dependence appearing as the primary indexed condition, and to 1 intervention - of which Contingency Management is the first listed.
NCT00842517 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00842517 about?
NCT00842517 is a clinical study titled "Long Term Maintenance of Drug Abstinence". The purpose of this study is to develop a model for long-term maintenance of behavior change by examining the effects of extending the duration of contingency management (CM) for drug abuse on long-term abstinence outcomes. The primary hypothesis is that the Extended (36 week) CM group will have bet...
What is the current status of trial NCT00842517?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 166 participants. The study started on 2004-09. Estimated completion is 2008-08.
What conditions does trial NCT00842517 study?
This clinical trial studies the following conditions: Cocaine Dependence, Cocaine Abuse.
What interventions are being tested in trial NCT00842517?
The interventions under investigation include: Contingency Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT00842517?
This trial is sponsored by Treatment Research Institute, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00842517 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cocaine Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00842517's enrollment target sits among peer trials
166 9th of 38 higher than 30 of 38 other Cocaine Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cocaine Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals
RECRUITING · Phase 1
-
Glutamate-Glutamine Cycling (VCYC) During Cocaine Abstinence Using 1H-MRS
COMPLETED · Phase 1
-
Complementary Combination Therapy for Cocaine Dependence
COMPLETED · Phase 1
-
Sex Differences in Progesterone Effects on Responses to Stress and Drug Cues
COMPLETED · Phase 1
-
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
COMPLETED · Phase 1
-
Caffeine and Cocaine
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia